Ginkgo Bioworks Holdings Inc (DNA)
0.7777
-0.07
(-8.05%)
USD |
NYSE |
Apr 25, 16:00
0.78
0.00 (0.00%)
Pre-Market: 09:21
Ginkgo Bioworks Holdings Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
Date | Value |
---|---|
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | |
March 31, 2021 | |
December 31, 2020 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2020
--
Maximum
Dec 2020
--
Average
--
Median
Dec 2020
Debt to Equity Ratio Benchmarks
Agenus Inc | -0.0805 |
Teladoc Health Inc | 0.6615 |
Sarepta Therapeutics Inc | 1.441 |
Ultragenyx Pharmaceutical Inc | 0.00 |
Apellis Pharmaceuticals Inc | 0.4783 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 1.665B |
Total Liabilities (Quarterly) | 568.19M |
Shareholders Equity (Quarterly) | 1.097B |
Current Ratio | 6.113 |